Singapore markets closed
Straits Times Index
3,323.20 -6.89 (-0.21%) S&P 500
5,306.04 +1.32 (+0.02%) Dow
38,852.86 -216.74 (-0.55%) Nasdaq
17,019.88 +99.08 (+0.59%) Bitcoin USD
67,797.84 -600.34 (-0.88%) CMC Crypto 200
1,462.67 -22.02 (-1.48%)
Marinus Pharmaceuticals, Inc. (61Y.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:00AM CEST. Market open.
| Previous close | 1.2500 |
| Open | 1.2500 |
| Bid | 1.3200 x N/A |
| Ask | 1.4300 x N/A |
| Day's range | 1.2500 - 1.2500 |
| 52-week range | 1.1800 - 10.2000 |
| Volume | |
| Avg. volume | 43 |
| Market cap | 81.936M |
| Beta (5Y monthly) | 1.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.4300 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 29.88 |
ZacksMerus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
Data from an earlier cut-off date shows that treatment with Merus' (MRUS) combination therapy achieved a 60% response rate in patients with head and neck cancer.
- Zacks
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
Iovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its combination therapy achieved an objective response rate of 65% in frontline advanced melanoma.
ZacksPfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
This is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first phase of this program is expected to save nearly $1.5 billion by 2027-end.
© 2024 Yahoo. All rights reserved.